Brainstorm Cell Therapeutics Inc. Forecast, price target & analysts
$0.88
3.69%
Nasdaq, Oct 09, 01:36 pm EDT.
Closed.
Brainstorm Cell Therapeutics Inc. Target price 2026 - Analyst rating & recommendation
Powered by
Brainstorm Cell Therapeutics Inc. Classifications & Recommendation
Hold
50%
Sell
50%
Brainstorm Cell Therapeutics Inc. Price Target
| Target Price | $17.34 |
| Price | $0.95 |
| Potential |
1,726.22%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Brainstorm Cell Therapeutics Inc. 2027 .
The average Brainstorm Cell Therapeutics Inc. target price is $17.34.
This is
1,726.22%
register free of charge
$17.85
1,779.94%
register free of charge
$17.17
1,708.32%
register free of charge
|
|
| A rating was issued by 6 analysts: 0 Analysts recommend Brainstorm Cell Therapeutics Inc. to buy, 3 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Brainstorm Cell Therapeutics Inc. stock has an average upside potential 2027 of
1,726.22%
register free of charge
|
Current Brainstorm Cell Therapeutics Inc. Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Maxim Group |
Locked
➜
Locked
|
Locked | Jul 23 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Maxim Group:
Locked
➜
Locked
|
Jul 23 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
